PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma.
PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma.
复制标题
PI3K/Akt/mTOR信号通路及胶质母细胞瘤靶向治疗
DOI:
10.18632/oncotarget.7961
复制
发表时间:
2016-05-31
期刊:
影响因子:
--
通讯作者:
Wang L
中科院分区:
文献类型:
--
作者:
Li X;Wu C;Chen N;Gu H;Yen A;Cao L;Wang E;Wang L
Glioblastoma multiform (GBM) is the most common malignant glioma of all the brain tumors and currently effective treatment options are still lacking. GBM is frequently accompanied with overexpression and/or mutation of epidermal growth factor receptor (EGFR), which subsequently leads to activation of many downstream signal pathways such as phosphatidylinositol 3-kinase (PI3K)/Akt/rapamycin-sensitive mTOR-complex (mTOR) pathway. Here we explored the reason why inhibition of the pathway may serve as a compelling therapeutic target for the disease, and provided an update data of EFGR and PI3K/Akt/mTOR inhibitors in clinical trials.
登录
查看更多内容
影响因子:
15.8
作者:
Cloughesy, Tim F.;Yoshimoto, Koji;Nghiemphu, Phioanh;Brown, Kevin;Dang, Julie;Zhu, Shaojun;Hsueh, Teli;Chen, Yinan;Wang, Wei;Youngkin, David;Liau, Linda;Martin, Neil;Becker, Don;Bergsneider, Marvin;Lai, Albert;Green, Richard;Oglesby, Tom;Koleto, Michael;Trent, Jeff;Horvath, Steve;Mischel, Paul S.;Mellinghoff, Ingo K.;Sawyers, Charles L.
通讯作者:
Sawyers, Charles L.
DOI:
10.1158/1078-0432.ccr-09-1837
发表时间:
2010-02-01
期刊:
Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子:
--
作者:
Ghobrial IM;Roccaro A;Hong F;Weller E;Rubin N;Leduc R;Rourke M;Chuma S;Sacco A;Jia X;Azab F;Azab AK;Rodig S;Warren D;Harris B;Varticovski L;Sportelli P;Leleu X;Anderson KC;Richardson PG
通讯作者:
Richardson PG
影响因子:
45.3
作者:
Chakravarti, A;Zhai, G;Loeffler, JS
通讯作者:
Loeffler, JS
影响因子:
10.3
作者:
Haas-Kogan, DA;Prados, MD;Stokoe, D
通讯作者:
Stokoe, D
影响因子:
11.5
作者:
Guerreiro, Ana S.;Fattet, Sarah;Arcaro, Alexandre
通讯作者:
Arcaro, Alexandre